Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

被引：0
|
作者：
Mei Gao
Miranda Lin
Richard A. Moffitt
Marcela A. Salazar
Jinha Park
Jeffrey Vacirca
Chuan Huang
Kenneth R. Shroyer
Minsig Choi
Georgios V. Georgakis
Aaron R. Sasson
Mark A. Talamini
Joseph Kim
机构：
[1] University of Kentucky,Department of Surgery
[2] University of Kentucky,Markey Cancer Center
[3] State University of New York,Department of Pathology
[4] City of Hope,Department of Experimental Therapeutics
[5] University of Iowa,Department of Radiology
[6] East Setauket,New York Cancer Specialists
[7] State University of New York,Departments of Radiology
[8] State University of New York,Departments of Psychiatry
[9] State University of New York,Departments of Medicine
[10] State University of New York,Departments of Surgery
来源：
British Journal of Cancer | 2019年 / 120卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：88 / 96
页数：8
相关论文
共 50 条
  • [1] Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
    Gao, Mei
    Lin, Miranda
    Moffitt, Richard A.
    Salazar, Marcela A.
    Park, Jinha
    Vacirca, Jeffrey
    Huang, Chuan
    Shroyer, Kenneth R.
    Choi, Minsig
    Georgakis, Georgios, V
    Sasson, Aaron R.
    Talamini, Mark A.
    Kim, Joseph
    BRITISH JOURNAL OF CANCER, 2019, 120 (01) : 88 - 96
  • [2] Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
    Mei Gao
    Miranda Lin
    Richard A. Moffitt
    Marcela A. Salazar
    Jinha Park
    Jeffrey Vacirca
    Chuan Huang
    Kenneth R. Shroyer
    Minsig Choi
    Georgios V. Georgakis
    Aaron R. Sasson
    Mark A. Talamini
    Joseph Kim
    British Journal of Cancer, 2020, 123 : 495 - 495
  • [3] Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer (vol 120, pg 88, 2019)
    Gao, Mei
    Lin, Miranda
    Moffitt, Richard A.
    Salazar, Marcela A.
    Park, Jinha
    Vacirca, Jeffrey
    Huang, Chuan
    Shroyer, Kenneth R.
    Choi, Minsig
    Georgakis, Georgios V.
    Sasson, Aaron R.
    Talamini, Mark A.
    Kim, Joseph
    BRITISH JOURNAL OF CANCER, 2020, 123 (03) : 495 - 495
  • [4] Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
    Hoshi, Ryunosuke
    Gorospe, Kristyna A.
    Labouta, Hagar I.
    Azad, Taha
    Lee, Warren L.
    Thu, Kelsie L.
    PHARMACEUTICS, 2024, 16 (09)
  • [5] Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
    Javed, Sadique A.
    Najmi, Asim
    Ahsan, Waquar
    Zoghebi, Khalid
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer
    Kadam, Pournima
    Sharma, Sherven
    VACCINES, 2020, 8 (02) : 1 - 13
  • [7] Oral immune checkpoint antagonists dually targeting TIGIT and PD-1 pathways for cancer therapy
    Sasikumar, P.
    Gundala, C.
    Patil, S.
    Naremaddepalli, S.
    Ramachandra, R.
    Gowda, N.
    Tangela, S.
    Adurthi, S.
    Dhudashia, A.
    Dodheri, S.
    Gowda, N.
    Nellore, K.
    Ramachandra, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E80 - E81
  • [8] Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas
    Ribatti, Domenico
    Cazzato, Gerardo
    Tamma, Roberto
    Annese, Tiziana
    Ingravallo, Giuseppe
    Specchia, Giorgina
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC
    Chen, Jing
    Alduais, Yaser
    Chen, Baoan
    CELL TRANSPLANTATION, 2021, 30
  • [10] Enhancement of immune checkpoint PD-1 blockade efficacy in ovarian cancer
    Drakes, Maureen
    Mehrotra, Swati
    Potkul, Ronald
    Liu, Yueying
    Stack, M. Sharon
    Stiff, Patrick
    CANCER RESEARCH, 2018, 78 (13)
12345